• Tidak ada hasil yang ditemukan

Selected Publications

N/A
N/A
Protected

Academic year: 2024

Membagikan "Selected Publications"

Copied!
2
0
0

Teks penuh

(1)

________________________________________________________________________________________________

Tel: +971 (6) 505 7651, Fax: +971 (6) 505 7652, P.O. Box: 27272, Sharjah -United Arab Emirates | www.sharjah.ac.ae I [email protected]

Selected Publications

1. Alzubaidi H, Sulieman H, Mc Namara K, Samorinha C, Browning C. The relationship between diabetes distress, medication taking, glycaemic control and self-management. International Journal of Clinical Pharmacy 2022; 4(1):127-137. doi: 10.1007/s11096-021-01322-2.

2. Alzubaidi H, Mc Namara K, Samorinha C, Saidawi W, Versace V, Speight J. Type 2 Diabetes Stigma Assessment Scale (DSAS-2): cultural and linguistic adaptation and psychometric assessment of the Arabic version. Primary Care Diabetes 2022;16(5):703-708. doi: 10.1016/j.pcd.2022.08.004.

3. Alzubaidi H, Austin Z, Saidawi W, Rees VW. Exploring the quality of smoking cessation in community pharmacies: A simulated patient study. Res Social Adm Pharm. 2022; 18(6): 2997- 3003. doi: 10.1016/j.sapharm.2021.07.013.

4. Alzubaidi H, Hasan S, Saidawi W, Namara KM, Chandir S, Krass I. Outcomes of a novel pharmacy screening intervention to address the burden of type 2 diabetes and cardiovascular disease in an Arabic-speaking country. Diabet Med. 2021;38(8):e14598. doi: 10.1111/dme.14598.

5. Basheti I, Mhaidat N, Al-Azzam S, Alqudah R, Nassar R, Alzubaidi H, Mahmoud SA, Abu-Gharbieh E. Knowledge and perceptions of pharmacists’ readiness during coronavirus pandemic: the case of United Arab Emirates. Journal of Pharmaceutical Policy and Practice 2021; 14(1):article no.102.

doi: 10.1186/s40545-021-00382-z.

6. Alzubaidi H, Samorinha C, Saidawi W, Hussein A, Saddik B, Scholl I. Preference for shared decision-making among Arabic-speaking people with chronic diseases: a cross-sectional study.

BMJ Open 2022; Apr 11;12(4):e058084. doi: 10.1136/bmjopen-2021-058084.

7. Mc Namara K, Alzubaidi H, Murray M, Samorinha C, Dunbar JA, Versace V, Castle D. Should antidiabetic medicines be considered to reduce cardiometabolic risk in patients with serious mental illness? Medical Journal of Australia 2022; 217(S7):S29-S33. doi: 10.5694/mja2.51701.

8. Samorinha C, Saidawi W, Saddik B, Abduelkarem A, Alzoubi K, Abu-Gharbieh E, Alzubaidi H. How is mental health care provided through community pharmacies? A quest for improvement.

Pharmacy Practice 2022; 20(2):1-12. doi: 10.18549/PharmPract.2022.2.2648.

9. Alzubaidi H, Samorinha C, Saddik B, Saidawi W, Abduelkarem A, Abu-Gharbieh E, Sherman S. A mixed-methods study to assess COVID-19 vaccination acceptability in the United Arab Emirates.

Human Vaccines and Immunotherapeutics 2021;17(11):4074-4082.

(2)

________________________________________________________________________________________________

Tel: +971 (6) 505 7651, Fax: +971 (6) 505 7652, P.O. Box: 27272, Sharjah -United Arab Emirates | www.sharjah.ac.ae I [email protected]

10. Abduelkarem AR, Samorinha C, Sharif SI, Hamrouni AM, Hassanein M. Distress symptoms during the COVID-19 lockdown: a study with the general population of the United Arab Emirates.

Pharmacy Practice 2022; 20(2):1-10. doi:10.18549/PharmPract.2022.2.2659.

11. Hasan S, Gamal M, Samorinha C, Hassan N. Antibiotic use numeracy: developing the Infectious Numeracy Test (INT). Research in Social and Administrative Pharmacy 2022; Mar 17;S1551- 7411(22)00062-6. doi: 10.1016/j.sapharm.2022.03.007.

12. Khalid Awad Ayoob Al-Kubaissi; Mohammed M Hassanein, Abduelmula R Abduelkarem.

Prevalence and Associated Risk Factors of Self-Medication with Over-the-Counter Medicines among University Students in the United Arab Emirates. Pharmac Practice 2022; 20(3):01-6. doi:

10.18549/PharmPract.2022.3.2679

13. Abduelmula R Abduelkarem, Anbar HS, Zaraei S-O, Alfar AA, Al-Zoubi OS, Abdelkarem EG, El- Gamal M. Diarylamides in anticancer drug discovery: A review of pre-clinical and clinical investigations. Eur. J. Med Chem. 2020;188:112029. doi.org/10.1016/j.ejmech.2019.112029.

14. Basheti I, Mahboub B, Salameh L, Al-Ani M, Abdulrahman AJ, Saddik B, Abu-Gharbieh E*.

Assessment of Novel Inhaler Technique Reminder Labels in Image Format on the Correct Demonstration of Inhaler Technique Skills in Asthma: A Single-Blinded Randomized Controlled Trial. Pharmaceuticals (Basel) 2021;14(2):150.

15. GBD 2019 Diabetes Mortality Collaborators, Abu-Gharbieh E, Saddik B. Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019. The lancet.

Diabetes & endocrinology, 10(3), 177–192. https://doi.org/10.1016/S2213-8587(21)00349-1 16. GBD 2019 Adolescent Mortality Collaborators, Abu-Gharbieh E, Saddik B. Global, regional, and

national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet 2021 Volume 398 Issue 10311: pages 1593- 1618. doi: 10.1016/S0140-6736(21)01546-4.

17. GBD 2019 Dementia Forecasting Collaborators. Abu-Gharbieh E. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022 Feb;7(2):e105-e125. doi:

10.1016/S2468-2667(21)00249-8.

Referensi

Dokumen terkait

The first two papers quantify the prevalence of maternal and child undernutrition and consider the short-term consequences in terms of deaths and disease burden, as

BioMed Central Pregnancy and Childbirth, 8 (42). Global burden of disease and risk factors. Oxford University Press and The World Bank. Socio-cultural factors as correlates

The incubation period of coronavirus disease 2019 COVID-19 from publicly reported confirmed cases: estimation and application.. Annals of internal

Keywords: metabolic risk, disability adjusted life year, death, United States, global burden of disease INTRODUCTION Metabolic risks, including high body mass index BMI, high fasting

Mental and Substance Use Disorders in GBD 2010 The Global Burden of Disease Study 2010 GBD 2010 [9] is the largest ever systematic effort to quantify the global distribution and

Overall, 45% of the world population lives in high prevalence regions hepatitis B surface antigen positivity rates > 8%, resulting in the massive global burden associated with the

Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease Improving Global Outcomes KDIGO.. Prevalensi dan Faktor

https://doi.org/10.3889/oamjms.2021.7472 eISSN: 1857-9655 Category: E - Public Health Section: Public Health Disease Control The Burden of Penile Cancer in Bali Compared to Other